Lilly hails Alzheimer's win with donanemab, boasting 'significant slowing of decline'
- info287308
- Jan 17, 2021
- 1 min read
The amyloid theory continues to grasp at life as Eli Lilly has unveiled new phase 2 data that can help by clearing these plaques out of the brain.
Comments